NICORETTE InvisiPatch 10mg/16h
Natural health product licensed in Canada
- Licence holder
- McNeil Consumer Healthcare, division of Johnson & Johnson Inc.
- NPN or DIN-HM
- 80022975
- Status
- Inactive licence
- Licence date
- 22 December 2010
- Revision date
- 2 February 2011
- Form
- Timbre transdermique
- Route of administration
- Transdermique
- Application type
- Non traditionnelle
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| (S)-3-(1-methyl -2-pyrrolidinyl)pyridine Source : Tobacco leaves | 15.75 mg |
| (S)-3-(1-methyl -2-pyrrolidinyl)pyridine Source : Nicotina tobaccum | 15.75 mg |
Non-medicinal ingredients
Polyethylene terephthalate, Durotak 387-2051, Butylated methacrylate copolymer, triglycérides à chaînes moyennes
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 1 patch | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
NICORETTE InvisiPatch 10 mg/16 hr offers controlled-release nicotine throughout the day to reduce withdrawal symptoms and nicotine cravings. To increase your chance of quitting use with a stop smoking support program. Combination Treatment: If you have relapsed or if you have had intense cravings or you feel like your cravings are overwhelming while using the patch alone, now you can use the patch in combination with NICORETTE Gum 2 mg for better craving relief. Combination Treatment: Use the patch as directed and chew 5-6 pieces of gum per day (maximum 15 pieces/day). Now, for the first time, you can wear NICORETTE Patch and chew NICORETTE Gum 2 mg together at the same time to help conquer those intense or overwhelming cravings and increase your chances of quitting vs. patch or gum alone.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80022975
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2011. Photograph the packaging to check whether it has changed. Photograph the packaging